Ellis Investment Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-916
Closed -$55K – 517
2022
Q3
$55K Buy
916
+1
+0.1% +$64 0.02% 380
2022
Q2
$57K Hold
915
– – 0.02% 388
2022
Q1
$64K Buy
915
+110
+14% +$7.44K 0.02% 384
2021
Q4
$50K Hold
805
– – 0.01% 422
2021
Q3
$49K Hold
805
– – 0.01% 400
2021
Q2
$48K Hold
805
– – 0.01% 401
2021
Q1
$49K Hold
805
– – 0.01% 388
2020
Q4
$38K Hold
805
– – 0.01% 412
2020
Q3
$29K Hold
805
– – 0.01% 437
2020
Q2
$28K Hold
805
– – 0.01% 428
2020
Q1
$22K Sell
805
-403
-33% -$17.9K 0.01% 396
2019
Q4
$62K Sell
1,208
-27
-2% -$1.3K 0.02% 311
2019
Q3
$56K Buy
1,235
+400
+48% +$19.1K 0.02% 320
2019
Q2
$42K Buy
+835
New +$39.2K 0.02% 348

Other funds holding MET

Ellis Investment Partners's MET Position: Q4 2022 in Review

Ellis Investment Partners sold out of MetLife (MET) in Q4 2022, closing a stake of 916 shares — an estimated $55K sold.

Ellis Investment Partners first reported a position in MET in Q2 2019 and held it in 14 quarters. The position peaked at $64K in Q1 2022. 1,314 funds tracked by Wall St. Rank hold MET as of Q4 2022.

  • Ellis Investment Partners reported no remaining MetLife position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 916 MetLife shares in Q4 2022, an estimated $55K.
  • Ellis Investment Partners first reported a position in MetLife in Q2 2019 and held it in 14 quarters.
  • Ellis Investment Partners's MetLife position peaked at $64K in Q1 2022.
  • 1,314 funds tracked by Wall St. Rank held MetLife as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.